EcoDrugPlus

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSCGOG00000013009
Gene Symbol: TRHR
3 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSCGOG00000005896
Gene Symbol: LOC115016108
3 Cross references
194 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSCGOG00000020427
Gene Symbol: LOC115022029
2 Cross references
171 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSCGOG00000002628
Gene Symbol: TLR2
3 Cross references
182 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSCGOG00000022310
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSCGOG00000022306
Gene Symbol: TLR8
1 Cross references
185 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSCGOG00000014795
Gene Symbol: TLR2
1 Cross references
211 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCGOG00000007671
Gene Symbol: TAAR1
1 Cross references
381 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCGOG00000007666
Gene Symbol: TAAR1
3 Cross references
381 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCGOG00000007660
Gene Symbol: TAAR1
1 Cross references
381 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCGOG00000007664
Gene Symbol: TAAR1
3 Cross references
381 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSCGOG00000012555
Gene Symbol: LOC115023463
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).